THE HOSPITAL PHARMACIST AS A MEMBER OF A MULTIDISCIPLINARY TEAM IN PERIOPERATIVE MANAGEMENT OF CHRONIC MEDICATION
CP-174
THERAPY EDUCATION PROGRAMME IN HEART FAILURE – 3 YEAR EVALUATION
CP-172
TYROSINE KINASE INHIBITORS IN THE TREATMENT OF RENAL CELL CARCINOMA IN ROUTINE CLINICAL PRACTICE
CP-171
USE OF ERIBULIN IN METASTASIC BREAST CANCER
CP-169
EFFECTIVENESS OF BIOSIMILAR FILGRASTIM VS ORIGINAL GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) IN FEBRILE NEUTROPENIA PREVENTION IN BREAST CANCER PATIENTS RECEIVING DOCETAXEL/DOXORUBICIN/CYCLOPHOSPHAMIDE (TAC)
CP-168
OBESE PATIENTS: ARE DOSE ADJUSTMENTS FOR TREATMENT OF COMORBIDITIES USED?
CP-167
EFFECTIVENESS OF THE NEW DIRECT-ACTING ANTIVIRAL AGENTS IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4